Adlai Nortye Raises $53M in Series B

Business, Health

Adlai Nortye Biopharma Co., Ltd. (“Adlai Nortye” or “the Company”), a biopharmaceutical company, announced that it has raised $53 million in a Series B financing round. Leading investors in biotech including YuanMing Capital, Matrix Partners China, DT Capital Partners, and Yahui Precision Medicine Fund participated in this funding round.

Adlai Nortye is a clinical-stage biopharmaceutical company focusing on the discovery, development and commercialization of novel treatments for cancer, with primary concentration on immuno-oncology. Adlai Nortye is advancing a robust pipeline of more than 10 diverse product candidates. Over 20 members of its executive and core research and development team have worked for years as executives at top-tier biopharmaceutical companies in the world. This new round of investment will strengthen Adlai Nortye’s position to become a leading biopharmaceutical company for innovative drugs.

Adlai Nortye has two clinical stage immune-oncology product candidates. Reolysin®, an intravenously delivered immuno-oncolytic virus (IOV) for the treatment of solid tumors is ready to enter Phase III study. FDA has granted Fast Track designation for Reolysin®. This will facilitate the development, and expedite the review of the drug. The first-in-class EP4 antagonist AN0025 to treat solid tumors is currently in Global Phase Ib trial.

“We are extremely delighted to have the trust and support from China’s premier investors in this financing round. Adlai Nortye is totally committed to the development of innovative drugs in immune-oncology. We will work tirelessly to enhance the lives of cancer patients with a goal to turn cancer into a chronic disease”, said Carsten Lu, CEO of Adlai Nortye.

“YuanMing Capital focuses our investment on outstanding companies in the medical space, especially in advanced companies in life sciences”, said Lawrence Y. Tian, Ph.D., founding partner of YuanMing Capital. “We are confident in Adlai Nortye’s potential to evolve into a leader in the field of immune-oncology. We hope to support the innovative research and development, and fuel the growth of the company through close collaboration with Adlai Nortye.”

“Adlai Nortye is dedicated to shaping itself into a global I/O company. It has demonstrated strong ability of innovation and act proactively in the I/O space. Adlai Nortye has a world-class team with rich global experiences and definitive focus on execution under the leadership of CEO Carsten Lu. It truly stands out among competitions worldwide with its deep understanding of the requirements for clinical trials. I look forward to an even brighter future for Adlai Nortye”, commented Eric Yu, Ph.D., Director of Matrix Partners China.

A Century After Umami’s Discovery, Its Benefits Continue to Expand

Food, Health

Umami, known as the savory taste, was discovered more than a century ago, yet recent research continues to document the benefits of umami. Currently underway is a year-long recognition of umami’s 110thanniversary since its discovery in 1908.

At one event this year, participants at the Asian Congress of Dietetics (ACD) will discuss the latest research on umami, including its dietary significance, during an ACD lunch symposium on Friday, July 6. The symposium ties in directly to the theme of the 7th ACD, which is “The Rise of Nutrition and Dietetics in Asia,” being held July 6-8 at the Hong Kong Polytechnic University.

The principal speaker at the lunch symposium will be Dr. Snigdha Misra, who is chair of the Department of Nutrition and Dietetics at International Medical University, in Malaysia. Dr. Snigdha will present the latest research demonstrating that umami improves the palatability of foods and stimulates appetite regulation, supporting nutrition among the elderly. Dr. Snigdha also will discuss how foods with umami seasonings are effective in reducing sodium intake and can help maintain normal blood pressure.

Dr. Snigdha notes, “The elderly face challenges in appetite due to decline in taste sensitivity. The addition of excessive sauces or dressings may make food appetizing, but could be detrimental to health due to the high sodium content. Umami enables food to be flavorful while lowering the sodium content of the food and stimulating appetite.”

According to the International Glutamate Information Service (IGIS), sponsor of the symposium, “It is fitting that ACD is focusing on the rise of nutrition in Asia. It was in Japan that 110 years ago Professor Kikunae Ikeda identified the ‘glutamic taste’ after isolating it from kelp broth. Dr. Ikeda was the first scientist to identify the unique properties of glutamate. He named the taste of glutamate ‘umami,’ which has a distinctive taste that is different from sweet, sour, bitter, and salty. Umami is now recognized as one of the five basic tastes. Dr. Ikeda’s driving goal was to improve nutrition of the Japanese with his umami seasoning.”

The IGIS is a non-profit organization communicating science-based information about umami, glutamate, and monosodium glutamate (umami seasoning). For more information, visit glutamate.org.

SOURCE International Glutamate Information Service

Entrepreneur Teams Up with Leading Psychiatrist to Address Depression, Anxiety, and Suicide

Health

Russell Pike, a successful entrepreneur and sports handicapper, is collaborating with renowned forensic psychiatrist Dr. Sanjay Sahgal in addressing the scourge of anxiety, depression, and suicide in our modern-day lives.

“When all of the noise of life was stripped away I began to hear God’s words in my heart and mind. It’s life-changing and redemptive,” says entrepreneur and author Russell Pike. “That’s certainly worth sharing with folks.”

Pike, who has penned several inspirational books and psychiatrist Sanjay Sahgal, MD have teamed up to begin the creation of a series of multi-media projects to address the increasing problem of depression, anxiety, and even suicide.

Dr. Sahgal, a Board-Certified Psychiatrist, and Assistant Professor of Psychiatry at USC Keck School of Medicine believes that psychiatry often doesn’t bring relief to people suffering from depression and anxiety. “I believe that there is a deeper need in people suffering from these maladies, that medicine can’t alleviate,” says Dr. Sahgal. “Russell Pike’s books and counsel have had a tremendous impact on my life and I am positive that his books will have a major impact on the lives of those that are battling depression and anxiety. I’m excited about working with him on these ventures.”

Pike began penning his first two books, Reminders From Heaven, Volumes 1&2, in 2012 while incarcerated at a federal prison camp. They are both now available at Amazon.com. Over the last five years Pike has written five sequels, all spiritual based books that provide inspiration and encouragement. While Reminders From Heaven are more biblically based in their sourcing, his subsequent books, Your Spiritual Reminders, Volumes 1-4 are for readers who are not as familiar with the Bible. In these subsequent books he shares the thoughts, insights, and encouragement from spiritual writers, thinkers, and leaders over the course of history. Every nugget on every page in every book is relevant to our everyday existence.

Russell Pike believes that regardless of the rollercoaster ride that life affords, it’s God’s truth and love that provide clarity and light in what is often a dark world. No one knows that better then him.

Pike’s entrepreneurial efforts brought him to the pinnacle of success as the founder of the popular energy drink company XYIENCE. The company sold for $200 million, but the conduct of his partners, and subjected IRS issues, resulted in late tax filings and his incarceration.

“If it wasn’t for a highly difficult period in my life I would never have been blessed with the opportunity to write these books and share the message with others, so that they can be encouraged every day,” says Pike. “Dr. Sahgal and I are of the same mind that our world is plagued by depression, hopelessness, and suicide, and that chemistry oftentimes is not the answer. I suffered from these conditions even when I was at the top of my game and they continually physically affected me with migraines and arthritis.”

The author makes it clear throughout his writing that it’s time we begin to immerse ourselves in words of light and love that give us hope and healing. Pike’s story also makes it clear that despite our mistakes, God is a God of Second Chances.

Russell Pike makes it even easier for his readers to benefit from these inspirational words by offering a free reminder app called Reminders From Heaven that is currently available in the Google Store and iTunes.

BBK Worldwide Repositions as The Patient Experience Company™ and Unveils New Brand Platform

Health, Technology

Patient Recruitment Pioneer Leverages Its Communications and Technological Expertise to Enhance the Clinical Trial Patient Journey

 

For 35 years, BBK Worldwide has been on the crest of the wave with regard to the development and evolution of the patient recruitment industry. Today, the company announces its new marketplace position as The Patient Experience Company. BBK’s promotion of its trendsetting commitment will be reflected in a redesigned company brand, including logo mark and website (bbkworldwide.com). The website details the services and technology-driven solutions devoted to educating consumers, engaging participants, unburdening sites, and supporting sponsors—the combination of which is essential for a company dedicated to enhancing the patient experience.

“Backed by efficacy data and market research, we’ve encapsulated everything we’ve learned to become The Patient Experience Company,” comments Joan F. Bachenheimer, founding principal and CEO, BBK Worldwide. “A critical component of an experience is ‘choice.’ Our technological platform, combined with our creative communications expertise, makes it possible for us to respond to stated preferences—whether expressed by site staff, patients, caregivers, CRAs, or sponsors—and more specifically, to meet the needs of individuals within those subsets. We are dedicated to the type of support that creates a positive synergistic effect.”

BBK leverages its experiential insights through ongoing Patient Voice and Site Voice initiatives. “Our research shows that even the most compliant of participants may still feel a sense of disenfranchisement,” comments Matt Kibby, principal and president, BBK Worldwide. “Engagement is not the same as experience.”

“Every phone call, office visit, and in-person interaction contributes to the overall participant experience,” explains Bonnie A. Brescia, founding principal and corporate development officer, BBK Worldwide. “Our orientation pays homage to the fact that nothing surpasses attention from medical and nursing providers with regard to creating a positive study experience for a participant. Our products and services are designed to alleviate administrative burden, enabling providers to spend more time with their patients.”

The company has a long history of appreciation for sponsor, CRO, patient, caregiver, and healthcare consumer needs. The Patients to Find the Cure® has been BBK’s tagline since its inception. Delivering the best experience at each key touch point in the patient journey guides BBK’s innovative approach to solving recruitment and engagement challenges.

BBK’s announcement coincides with the Annual Meeting of the Drug Information Association in Boston, June 24–28, 2018. Reporters interested in speaking with BBK can visit booth #1607, or they may contact Elizabeth Gargill by phone at 617-630-5513 or by email at egargill@bbkworldwide.com.

15 Year Old, Worth Estimated £1.5 Million, Auctions Exclusive World-Record Breaking Chelsea Flower Show Artwork for Wessex Cancer Trust

Art, Health

The auction for special edition pieces of artwork from the RHS 2018 Chelsea Flower Show is now live.

The world-famous flower show took place in May and at the heart of the Great Pavilion sat “mini-Monet”, Kieron Williamson, a 15 year old art phenomenon whose work has sold for hundreds of thousands of pounds, despite his young age.

Kieron is one of the world’s most sought after professional young artists with a global waiting list of art enthusiasts that eagerly look forward to his next masterpiece. His first painting sold for a phenomenal £14,000 when he was just six years old; he has gained media attention around the world and his work has been secured for many prestigious private collections, including Royalty.

Kieron latest masterpieces were created at the Chelsea Flower Show having been commissioned by Hillier Nurseries to capture scenes from its “Stihl Inspiration” garden. He gained attention from many high-profile people at the show, and subsequently since.

Hillier, which holds the world record for having the most consecutive gold medals in the history of the show, received its 73rd gold medal at this year’s Chelsea and has now launched the auction to raise proceeds for its charity partner, Wessex Cancer Trust.

Kieron has created two paintings for the auction – “Lupins at Chelsea” and “Blue Waves and Goldrush”. Each piece has been valued, and bidding starts at £3,995.

Discussing the partnership with Hillier, Kieron commented: “Working with Hillier has been fantastic. I was so inspired by the Stihl Inspiration garden that it was hard to choose what to paint! I chose to paint the area that had the most colour diversity. I love painting the outdoors and nature scenes so being part of the Chelsea Flower Show was an experience I’m never going to forget!”

George Hillier, one of the fifth generation of Hillier family members to be involved in the business, said: “Kieron is such an amazing talent. It was fascinating watching him painting at the show, he certainly pulled in a crowd and people were amazed by him. We’re delighted to be working with Kieron to offer people the chance to own his next piece of artwork, not to mention something from the Chelsea Flower Show gold medal world record holders!”

To view the auction please visit http://www.hillier.co.uk/chelsea-auction.

California Cryobank And Cord Blood Registry To Be Combined By GI Partners To Create A Leading Life Sciences Platform

Business, Health

California Cryobank, the world’s leading donor sperm and donor egg bank, announced today that it has signed a definitive agreement for GI Partners, a private equity investment firm, to acquire the company from leading healthcare investors Longitude Capital and NovaQuest Capital.

In a separate transaction announced today, GI Partners has also entered into a definitive agreement with AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) to acquire Cord Blood Registry (CBR), the world’s largest stem cell collection and storage company. Following the close of both transactions, California Cryobank and CBR will join together in a newly combined entity that will operate under the California Cryobank Life Sciences platform, bringing together best-in-class organizations to provide enhanced domestic and international expansion opportunities in both the donor reproductive tissue and newborn stem cell industries.

Dave Kreter, Managing Director at GI Partners said, “We have been following the growing and dynamic reproductive and stem cell space for several years and were attracted to these two companies by their robust customer and market characteristics. Their combination represents a unique opportunity to create a new platform better positioned to further expand their industry leading capabilities. We are excited to collaborate with management to extend the combined company’s capabilities internationally and make critical investments to support its next phase of growth.”

Recognized as the world’s premier donor sperm and egg bank, California Cryobank has been an industry leader and innovator since 1977. Together, the donor sperm and donor egg banks have helped over 75,000 families.

Richard Jennings, California Cryobank CEO, commented that: “The Life Sciences platform created by the combination of our two companies will allow us to utilize our collective strengths more effectively, and achieve our vision of helping to grow and protect healthy families around the world. CBR is the most recognized cord blood brand among expectant parents and we are excited to expand CBR’s presence in the newborn stem cell market even further given California Cryobank’s global footprint. Cord blood and cord tissue offer a once-in-a-lifetime opportunity to protect families against 80 diseases, and give clients the biologic resource to utilize clinical therapies within regenerative medicine.”

“We are bringing together the leaders in two complementary, family-focused industries,” explained California Cryobank COO Pamela Richardson. “Both organizations set the standard for clinical excellence, customer experience, physician relations, and overall quality. The combination will provide enhanced value to our clients. CBR is a perfect fit with California Cryobank’s mission of providing the highest quality reproductive and stem cell services, guided by dedicated customer focus, unmatched scientific excellence, and innovative leadership.”

Dr. Greg Grunberg, Managing Director at Longitude Capital said, “Over the course of the last four decades, California Cryobank has helped countless families achieve their most fundamental of aspirations. We are thrilled to provide our continued support to our world class management team, which upholds the highest moral, ethical, and scientific standards, as California Cryobank expands its vital services and advances the fields of reproductive and regenerative medicine.”

William O. Robb, Founding Partner of NovaQuest Capital Management added, “The combination of CCB and CBR demonstrates this management team’s success in positioning California Cryobank Life Sciences as the leading reproductive services platform in the world. The immediate and longer-term synergies between CCB and CBR in donor sperm, donor egg, and stem cell services will create a critical partner to the families, physicians, and other key stakeholders in the growing reproductive sciences field.”

Stayfree India Equips Commercial Sex Workers With Essential Life Skills Through Project Free Period

Health, Safety, Society

The unique vocational training program, organised by Johnson & Johnson India, helps women sustain themselves outside the sex trade

Stayfree India’s Project Free Period – a vocational training program for commercial sex workers – is empowering women to hone their skills and cultivate their own ‘Dreams of Progress’.

Launched in partnership with DDB Mudra Group and NGO Prerana, Project Free Period stems from the idea that while several women often dread their period days, for those in the sex trade, it earmarks the time of the month that they get for themselves. Thus, this initiative is aimed at converting the days of their period into days of vital learning.

Project Free Period entails multiple workshops condensed into three-day training modules where the women are taught a range of skills that include candle-making, embroidery, henna art and a basic beauticians’ course. The first edition of this programme, launched in the red light district of Mumbai, has witnessed the participation of over 30 women till date.

Commenting on the campaign, Dimple Sidhar, Vice President – Marketing, Consumer Products Division, at Johnson & Johnson India, said, “While the 21st century India is making great strides in the areas of education and economic independence amongst women, we continue to fight against the long-standing prejudices around tabooed subjects like prostitution. Thus, we at Stayfree want to economically empower women from all backgrounds while also ‘normalizing periods’.”

Further remarking on the campaign, Rahul Mathew, National Creative Director, DDB Mudra Group said, “To go from normalizing periods in the lives of women to using periods to normalize the lives of women in the sex trade; is a great example of the kind of power and influence brands can wield. Project Free Period turns the period from a pause to an opportunity, for these women to sustain a life outside of the trade.”

Through recruitment drives on social media, the initiative has also put together a database of volunteers to keep scaling up this project. Stayfree India and DDB Mudra Group are now looking to partner with other non-profit organizations to replicate this model and access a wider database of students and volunteers going forward.

Mugdha Dandekar, Project Manager, Prerana said, “This project brings a chance for the women in the red-light areas to step out of the exploitative lifecycle. Uneducated and with no income security, such an opportunity to learn an alternative vocation is crucial. The women have chosen the days they would like to come for the training, so that it doesn’t disrupt their lives. The change has to be gradual, not on weekly or monthly basis, and this project understands that. Therefore, we see a strong commitment from our women to hold on to this opportunity and give change a chance.”

Watch the full video here:

.

Actress Chéri Ballinger Invests in LifeStory Health, Inc. — A Bio-Science Company Advancing Women’s Healthcare

Health

BOSTON, — Actress Chéri Ballinger has invested in LifeStory Health, Inc. (LSH), a bio-science start-up developing novel diagnostics and potential therapeutic targets for early detection and treatment of female prevalent diseases. Ballinger, who survived a traumatic brain injury in 2014, earmarked her investment to fund a 2018 research study for early onset Alzheimer’s disease which will be completed with a nationally recognized research university in Boston, MA.

An advocate for women’s health and brain injuries, Ballinger’s personal story aligns with LifeStory Health’s mission to advance women’s healthcare and raise awareness of the need for more sex-specific testing. “It’s very important to me to use my second chance at life to help as many people as I possibly can. For me, this is personal, and it’s my mission,” said Ballinger.

For Ballinger, investing in LSH complements her work with the Women’s Brain Project, a non-profit group based in Switzerland. “LifeStory Health is such a great fit for the Women’s Brain Project. As an ambassador for the organization, I see how essential it is for us to collaborate so our international advocacy can support more change, advance medical science, and raise awareness for the specific needs in women’s healthcare,” continued Ballinger, “together we are so much stronger.”

Ballinger’s support will help expand LSH’s research and amplify awareness of sex specific testing to meet the unmet medical needs of diseases disproportionately impacting women, including neurodegenerative diseases and several types of cancers.”LifeStory Health is on the forefront of accelerating women’s healthcare and Chéri’s contribution and increased involvement highlights the confidence investors are seeing in our research,” said LifeStory Health Founder and CEO Anna Villarreal.

Scheduled to conclude in Q3 of 2018, LSH’s study will provide much needed insight into how Alzheimer’s disease impacts women. Nearly two-thirds of the 5.4M Americans suffering from Alzheimer’s disease are female. When looking at early onset Alzheimer’s, women represent 75% of the population. The disparity between female and male is compounded by the fact that brain studies in males outnumber females by 5 to 1.

“Not only is LifeStory Health changing the clinical testing paradigm but we are changing how both individuals and organizations invest in life science companies”, said Villarreal. “Accelerating healthcare through our novel approaches will provide an impact for over half the population, and to have this ‘for women, by women’ investment marks a truly humbling event.”

LifeStory Health’s early onset Alzheimer’s study marks one of three studies LSH will begin in 2018. The others include early stage breast cancer and pre-diabetes.

Internet Brands’ WebMD Acquires Jobson Healthcare Information

Business, Health

WebMD Health Corp., an Internet Brands company and the leader in health information services for consumers and physicians, today announced that it has acquired Jobson Healthcare Information (JHI), a leading provider of information, education and marketing services in key healthcare markets.

Owning brands that have been leaders for over 50 years, JHI has long been recognized for its diversified portfolio of healthcare information, education and marketing services targeted to a broad segment of the healthcare industry, including physicians, pharmacists and eye care professionals. Through its comprehensive product offerings and platforms, JHI can reach more than one million healthcare professionals.

“JHI’s commitment to delivering quality information and services to the healthcare industry makes them an excellent addition to the WebMD network,” said CEO Steve Zatz, M.D.  “They complement our existing capabilities and contribute very strong positions with pharmacists and the eye care community.  JHI will help expand and deepen our relationships with health care professionals and enable us to leverage our combined strengths to increase our value to our customers.”

“WebMD is an exceptional fit for JHI,” said JHI CEO Jeff MacDonald.  “In addition to sharing our passion for helping health care professionals improve the quality of patient care, WebMD’s substantial digital resources will enable us to bring more critical data, communications and information to health care professionals.  We look forward to all we can accomplish together.”

Also headquartered in New York City, JHI will continue to operate as an independent subsidiary of WebMD. JHI was represented by JEGI in the transaction.  Terms of the transaction were not made public.

Disappearing A’s, B’s and O’s: Red Cross launches #MissingType campaign to urge new blood donors to give

Health, World

New survey reveals the public underestimates how frequently lifesaving blood transfusions are needed

 

Today, the American Red Cross launches the Missing Types campaign, an international effort to encourage new blood donors, as well as donors who have not given in years, to give blood and to help ensure lifesaving blood products are available for patients in need.

As part of the campaign, the letters A, B, and O – letters used to identify blood types – are disappearing across the country and around the world from corporate logos, favorite brands and frequently visited websites. Many may not realize just how important these three letters can be until they are gone.

“Everyday thousands of patients across the United States rely on generous blood donors for critical blood transfusions,” said Gail McGovern, president and CEO of the Red Cross. “However, we have seen a troubling decline in the number of new blood donors. We urge the public to roll up a sleeve and fill the missing types before these lifesaving letters go missing from hospital shelves.”

In fact, for the past four years, new Red Cross donors have declined by about 80,000 each year. The blood donor base is shrinking. This is not just a Red Cross trend, but a challenge blood collection organizations face across the country and around the world – which is why many are rallying behind this campaign today. Missing Types highlights just how important A’s, B’s, and O’s are – After all there is no _meric_n Red Cr_ss without the A’s and O.

Join the #MissingType movement—make an appointment to give blood by visiting redcrossblood.org, using the Red Cross Blood Donor App or calling 1-800-REDCROSS (1-800-733-2767). All blood types are needed.

Survey shows public misconceptions about blood needs
A recent survey, conducted on behalf of the Red Cross, revealed a troubling disconnect between the public’s perception of blood donations and the realities of patient transfusion needs.

Three-quarters (74 percent) of the public underestimate how frequently blood transfusions occur.* Most people perceive blood is needed in the U.S. every 15 minutes or even every hour or two hours when in fact, every two seconds, someone in this country needs blood.

Nearly half of the public (45 percent) know someone who has been helped by a blood transfusion.* Yet only three percent of the U.S. population donates each year.

More than one-third (35 percent) of the public has never considered that blood may not be available when they or a loved one need it.* Blood shortages are not uncommon in the United States and can only be prevented when more people roll up a sleeve to give.

More than half (53 percent) of the public believe they need to know their blood type to donate.* Good news – Potential blood donors do not need to know their blood type before giving blood. After individuals give blood, the Red Cross provides each donor their blood type. Join the movement and find out your blood type this summer.
A missing letter can change everything for a patient
Tymia McCullough, of Georgetown, S.C. is a spirited 12-year-old who aspires to be a pediatrician and model when she grows up. She is also battling sickle cell disease, an inherited disease that causes red blood cells to form an abnormal crescent shape. Sickle cell disease patients can suffer a range of conditions, including acute anemia, tissue and organ damage, terrible pain and even strokes.

With no widely used cure, regular blood transfusions are one of the most common treatments for sickle cell disease. Last year, when McCullough arrived at the hospital, the blood type she needed for her transfusion was not available.

“It was the scariest, most frightening moment of a mother’s life, because I thought that she would not be able to get it,” said Susie Pitts, Tymia’s mother. “In that moment, in that experience, I was very afraid. I was scared for my daughter’s life—what was going to happen if she didn’t get the blood she needed?”

Eight hours later, the nurse came running through the door with the needed blood product.

Watch Tymia’s story.

Partners join the movement to raise visibility
The Red Cross appreciates the support of its lead partners who have joined the Missing Types campaign, including: Adobe, Anheuser-Busch, AvalonBay Communities, Inc., Domino’s, Dropbox, Google, IBM, Land O’Lakes, Inc., Mastercard, Nationwide, Neiman Marcus, the New York Yankees, Oreo, PayPal, Salesforce, State Farm®, Sunoco and U.S. Bank.

Each day, blood and platelets are needed for accident and burn victims, heart surgery and organ transplant patients, and those receiving treatment for leukemia, cancer or sickle cell disease. We are grateful for our partner support to raise visibility for this ongoing need.

Blood donation information
All blood types are needed to ensure a reliable supply for patients. A blood donor card or driver’s license or two other forms of identification are required at check-in. Individuals who are 17 years of age in most states (16 with parental consent where allowed by state law), weigh at least 110 pounds and are in generally good health may be eligible to donate blood. High school students and other donors 18 years of age and younger also have to meet certain height and weight requirements.

Blood and platelet donors can save time at their next donation by using RapidPass® to complete their pre-donation reading and health history questionnaire online, on the day of their donation, before arriving at the blood drive. To get started, follow the instructions at RedCrossBlood.org/RapidPass or use the Red Cross Blood Donor App.

Supplemental Information about Survey Methodology
*These are the findings from an Ipsos poll conducted April 16 – 18, 2018 on behalf of the Red Cross. For the survey, a sample of 503 adults ages 18 and over from the continental U.S., Alaska and Hawaii was interviewed online, in English. The precision of Ipsos online polls is measured using a credibility interval. In this case, the poll has a credibility interval of ±5.0 percentage points for all respondents surveyed.